Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.95% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BGLC · Jun 30, 2025
BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001477932-25-006023General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-32.65% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
14.47% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
53.78% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
16.28% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-27.05% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.56% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.42%
- Current
- 0.95%
- Delta
- 0.53%
- Previous
- -38.56%
- Current
- -32.65%
- Delta
- 5.91%
- Previous
- -10.28%
- Current
- 14.47%
- Delta
- 24.75%
- Previous
- 55.18%
- Current
- 53.78%
- Delta
- -1.39%
- Previous
- 16.07%
- Current
- 16.28%
- Delta
- 0.21%
- Previous
- -28.94%
- Current
- -27.05%
- Delta
- 1.89%
- Previous
- 0.57%
- Current
- 0.56%
- Delta
- -0.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BGLC Fundamental State →Transitioned To · BGLC Fundamental State →Transitioned To · BGLC CAPEX_INTENSITY_INCREASED →Transitioned To · BGLC CASH_GENERATION_INCREASED →Transitioned To · BGLC GROWTH_INCREASED →Transitioned To · BGLC INVENTORY_PRESSURE_DECREASED →Transitioned To · BGLC MARGIN_INCREASED →Transitioned To · BGLC PROFITABILITY_INCREASED →Transitioned To · BGLC R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.